TCPI's purchase of Pharma Patch adds transdermal drug expertise to diagnostic business.
This article was originally published in The Tan Sheet
Executive Summary
TECHNICAL CHEMICALS' PROPOSED ACQUISITION OF PHARMA PATCH would add expertise in transdermal drug delivery to Technical Chemicals and Products' professional and OTC diagnostics business. The companies recently announced the signing of a letter of intent under which TCPI would acquire all the business assets and operations of Pharma Patch for $17 mil. "The marriage of these two companies' technologies will create a significant impact on both diagnostic and pharmaceutical markets," TCPI Chairman and President Jack Aronowitz predicted.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning